Amag Pharmaceuticals (AMAG) Stock News

NASDAQ:AMAG - Nasdaq -

13.75 +0.02 (+0.15%)

After market: 13.76 +0.01 (+0.07%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AMAG Latest News, Press Relases and Analysis

All

Press Releases

5 years ago - By: Covis Pharma

Covis Group Completes Acquisition of AMAG Pharmaceuticals

5 years ago - By: Capital Market Laboratories

Identifying When a Stock is (Precisely) Oversold - The Stock Trigger in AMAG Pharmaceuticals Inc

5 years ago - By: Capital Market Laboratories

Pre-earnings Momentum Trade With a Technical Trigger in AMAG Pharmaceuticals Inc

5 years ago - By: Zacks Investment Research

AMAG Pharmaceuticals (AMAG) Earnings Expected to Grow: Should You Buy?

5 years ago - By: Analyst Ratings

News Image

Leerink Partners Maintains Their Hold Rating on Amag Pharmaceuticals (AMAG)

5 years ago - By: Halper Sadeh LLP - Mentions: BMCH VRTU

INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – AMAG, BMCH, VRTU

5 years ago - By: Benzinga - Mentions: ALRN NVCR FOLD SIBN ...

The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout

5 years ago - By: Covis Pharma

Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.

5 years ago - By: Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AMAG Pharmaceuticals, Inc. - AMAG

5 years ago - By: Kahn Swick & Foti, LLC

AMAG PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AMAG Pharmaceuticals, Inc. - AMAG

5 years ago - By: Benzinga - Mentions: PLSE XBI LSAC HZNP ...

The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation

5 years ago - By: Seeking Alpha

FDA provides further update on Amag Pharma's Makena approval (NASDAQ:AMAG)

5 years ago - By: Zacks Investment Research - Mentions: EBS HZNP LGND

AMAG (AMAG) to be Acquired by Covis Group for $647 Million

5 years ago - By: WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Investigates AMAG Pharmaceuticals, Inc.

5 years ago - By: Bloomberg - Mentions: ARA APO

HPS to Lend $1 Billion for Health Care M&A in Private Debt Push

5 years ago - By: Rowley Law PLLC

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of AMAG Pharmaceuticals, Inc.